14 results
20-F
2021 FY
IINN
Inspira Technologies Oxy B.H.N. Ltd
31 Mar 22
Annual report (foreign)
4:48pm
believe that due to the potential ease of use and affordability of the ART, we will also be able to target smaller urban and rural hospitals that do
424B4
IINN
Inspira Technologies Oxy B.H.N. Ltd
15 Jul 21
Prospectus supplement with pricing info
4:06pm
or similar foreign regulatory bodies, we believe that due to the potential ease of use and affordability of the ART500, we will also be able to target … by the FDA or similar foreign regulatory bodies, we believe that due to the potential ease of use and affordability of the ART500, we will also be able
F-1/A
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Jul 21
Registration statement (foreign) (amended)
11:58am
foreign regulatory bodies, we believe that due to the potential ease of use and affordability of the ART500, we will also be able to target smaller … or approved by the FDA or similar foreign regulatory bodies, we believe that due to the potential ease of use and affordability of the ART500, we
F-1/A
l86v gkgh
28 Jun 21
Registration statement (foreign) (amended)
11:41am
F-1/A
vu18q3iirdr6o4e
8 Jun 21
Registration statement (foreign) (amended)
5:26pm
F-1/A
w0s14kak37
29 Mar 21
Registration statement (foreign) (amended)
5:19pm
F-1/A
n3117pf4 sua7
22 Mar 21
Registration statement (foreign) (amended)
11:24am
F-1
ortaqdg mpzq1
5 Mar 21
Registration statement (foreign)
3:03pm
DRS/A
04r9oj5ivtpn1w8fx62l
17 Feb 21
Draft registration statement (amended)
12:00am
DRSLTR
1bhq1m 1wr6sui
17 Feb 21
Correspondence regarding draft registration statement
12:00am
UPLOAD
we15xd1160475xo ac
28 Jan 21
Letter from SEC
12:00am
DRS
2vdsjk1ybivb
29 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next